Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Scientists Look Into Why Most Alzheimer's Patients Are Women

June 29, 2015 9:42 am | by Lauren Neergaard, AP Medical writer - Associated Press | News | Comments

Nearly two-thirds of Americans with Alzheimer's disease are women, and now some scientists are questioning the long-held assumption that it's just because they tend to live longer than men. Read more..

TOPICS:

TSRI and Biotech Partners Find New Antibody Weapons against Marburg Virus

June 29, 2015 9:34 am | by The Scripps Research Institute | News | Comments

A new study led by scientists at The Scripps Research Institute (TSRI) identifies new immune molecules that protect against deadly Marburg virus, a relative of Ebola virus. The research provides ingredients needed to develop treatments for future Marburg outbreaks. Read more...

TOPICS:

Turning the Tables on Cancer

June 29, 2015 9:29 am | by Shari Roan, UCLA | News | Comments

A new class of immunotherapies is enlisting the body's own immune system to fight cancer. Read more...

TOPICS:
Advertisement

Blood Test IDs Pancreatic Cancer in 250 of 250 Patients

June 29, 2015 9:18 am | by Cynthia Fox, Science Editor | Articles | Comments

A new blood test identified pancreatic cancer with 100 percent accuracy in 250 of 250 patients, said a recent report in Nature. The test found pancreatic exosomes in blood via the biomarker GPC1. It distinguished early-stage cancer from late-stage cancer—with zero false positives/negatives. It predicted survival. Read more...

TOPICS:

Novartis Acquires U.S. Biotech Firm Spinifex

June 29, 2015 8:45 am | by The Associated Press | News | Comments

Novartis didn't disclose financial details Monday of the agreement. Read more...

TOPICS:

Major Step for Implantable Drug Delivery Device

June 29, 2015 8:41 am | by MIT | News | Comments

An implantable, microchip-based device may soon replace the injections and pills now needed to treat chronic diseases. Read more...

TOPICS:

Ascletis Files Clinical Trial Applications for Hepatitis C Drugs in China, Taiwan

June 29, 2015 8:30 am | News | Comments

Ascletis is now the first Chinese company to file clinical trial applications in China for an IFN-free regimen. Read more...

TOPICS:

DNA Damage Linked with Dementia

June 29, 2015 8:29 am | by University of Sheffield | News | Comments

High levels of DNA damage in nerve cells can lead to dementia. Read more...

TOPICS:
Advertisement

EU Recommends Approval of Roche's Pre-Surgery Breast Cancer Treatment

June 29, 2015 8:29 am | News | Comments

The majority of breast cancer cases are diagnosed at an early stage of the disease, before the cancer has spread to other parts of the body. Read more...

TOPICS:

EU Recommends Approval for Alexion's Rare Disease Drugs

June 29, 2015 8:26 am | News | Comments

The drugs are called Strensiq and Kanuma. Read more...

TOPICS:

Allergan Layoffs Done at Irvine Location; Kythera Cuts in Question

June 26, 2015 1:35 pm | by Ryan Bushey, Associate Editor | Articles | Comments

The CEO of Allergan discussed the future of his company after the completion of the Actavis merger. Read more...

TOPICS:

Drug Discovery Spotlight: ASCO’s Cancer Drugs Rating Scale; Hepatitis C Drug Patent Rejected in China

June 26, 2015 12:59 pm | by Stephanie Guzowski, Editor | News | Comments

The American Society of Clinical Oncology said it would provide a rating scale for cancer drugs, and now it’s delivered — and not all the score results are assuring. Pharma’s next five years look promising, according to an industry report. Read more...

TOPICS:

California Vaccine Bill Clears Legislative Hurdle

June 26, 2015 10:43 am | by Seth Augenstein, Digital Reporter | News | Comments

A split California Assembly approved a bill that would require nearly all public school kids to get basic vaccines Thursday. The bill passed on a bipartisan 46 to 30 vote and, if signed by the governor, would give California one of the strictest vaccine requirements, by eliminating the “personal belief” exemption used by anti-vaccine parents. Read more...

TOPICS:

Janssen Schizophrenia Treatment Now Commercially Available

June 26, 2015 10:37 am | News | Comments

The first schizophrenia treatment to be taken just four times a year – with dosing measured in seasons, not days – is now available in the United States. The three-month dosing interval of Invega Trinza (paliperidone palmitate) offers a new paradigm for treating patients with schizophrenia. Read more...

TOPICS:

Delivering Drugs to the Right Place

June 26, 2015 9:27 am | by UC Santa Barbara | News | Comments

For the 12 million people worldwide who suffer from polycystic kidney disease (PKD), an inherited disorder with no known cure, a new treatment option may be on the horizon. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading